Friedrich-W. Gause
CO-FOUNDER & MANAGING PARTNER
CONTACT DETAILSBerlin Office »
Phone: +49 30 814 871 26 |
CURRICULUM VITAEFriedrich-W. Gause is a Co-founder and a Managing Partner at BGM Associates. He has held management and executive positions in Schering AG, Intendis GmbH and Bayer Healthcare, primarily associated with ethical pharma products, in vivo diagnostics and medical devices for oncology, neurology and dermatology. He guided the spin-off of Schering’s Dermatology business and led the Intendis' Dermatology operations in Germany.
For more than 8 years Friedrich has worked in Asia, leading the build-out of the Medical Marketing and Sales functions of Schering’s Pharma Joint-Venture in China, headed the Bayer Healthcare Division and served as the Senior Bayer Representative in South Korea. Friedrich chaired the Pharmaceutical Committee of the EU Chamber of Commerce in Korea (EUCCK) and supported the Korean Research-based Pharmaceutical Industry Association (KRPIA) as a Vice-Chair. From 2013 to 2015, Friedrich served as a COO of the molecular imaging startup Piramal Imaging, where he has driven the buildup of the commercial organization and distribution network in the US, Europe and Asia/Pacific including the launch of Piramal’s leading brand NeuraceqTM, a PET/CT tracer for imaging of patients suspected to suffer from Alzheimer’s Disease. Since 2016, Friedrich is Chairman of the Advisory Board of the Berlin-based digital healthcare start-up Medicinisto AG. Friedrich holds a Dipl.-Ing. degree in chemical engineering and business administration from the Technische Universität Berlin. |
|
|
PAST CONTRIBUTIONSHealthcare in the next ten years: Challenges and solutions. BGM Associates Healthcare Roundtable Report, 2014
EUCCK 2011 Market Access Issues – Position Paper Healthcare: Pharmaceuticals Committee. Website of The European Union Chamber of Commerce in Korea, www.eucck.org/site/publications Korea – EU FTA to put Seoul at Public Health Crossroads. Interview Article in Korea Herold, July 8 2011 KGCCI Economic Outlook 2011 – The Pharmaceutical and Petro-Chemical Markets. Symposium of the Korean-German Chamber of Commerce and Industry, Seoul, January 24, 2011 Korea-EU FTA and Corporate Strategy in the Globalization Era, Compliance Framework in the Medical Industry –The Company Perspective. Session Moderator and Panelist, Seoul December 8, 2010 Strategies and Cooperation for Bio-Economy in Asia – The Industry Perspective. Panel Discussion at Korea Bio-Economy Forum, Seoul, May 26, 2010 Preisbestimmung und -administration erstattungsfaehiger Arzneimittel in Korea. Kompakt - Beitrag in KGCCI / KORUM Nr. 6, Dezember 2009 |